In 2025, the MedTech industry faced challenges with shifting trade policies and reduced federal funding impacting companies. Despite this, the industry generated $584 billion in revenues, with M&A activity focusing on innovation and high-growth markets. Companies like Intuitive Surgical, Boston Scientific, Insulet, and IDEXX Laboratories are poised for growth in 2026.

Technological progress in MedTech includes AI integration in devices, with the FDA authorizing over 250 AI-enabled devices by September 2025. Companies like Intuitive Surgical, Boston Scientific, Insulet, and IDEXX Laboratories are incorporating data science and AI/ML into their products, enhancing competitiveness and market positioning.

Key medical advances in 2025 include regenerative medicine, digital twins, and AI-powered robotic surgery. These technologies offer promising solutions for treating various injuries and diseases, with applications in simulation, personalized treatment strategies, and improved surgical outcomes.

The global medical device market is projected to grow at a CAGR of 5.94% from 2026 to 2035, with companies like Intuitive Surgical, Insulet, Boston Scientific, and IDEXX Laboratories leading the way. These companies have favorable growth outlooks, innovative products, and strong financial performance, making them attractive investment options for 2026.

Read more at Nasdaq: 4 Medical Device Stocks to Buy for Healthy Returns in 2026